SCHEMBL20502811

SCHEMBL20502811

Cc1cc2c(c(Br)c1C)Cc1ccccc1-2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 2/20 0.38
PNMT P11086 1/20 0.38
ALDH1A1 P00352 3/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAOA P21397 2/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA4 P22748 1/20 0.34
CA6 P23280 1/20 0.34
MAP3K9 P80192 1/20 0.34
MAP3K11 Q16584 1/20 0.34
CYP1A2 P05177 3/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1871451 0.86 PNMT (0.38) PGRPNMTALDH1A1NPC1RAB9A
SCHEMBL6256393 0.86 PGR (0.43) PGRPNMTALDH1A1NPC1RAB9A
SCHEMBL29177673 0.84 PGR (0.42) PGRPNMTALDH1A1NPC1RAB9A
SCHEMBL30103698 0.84 PGR (0.42) PGRPNMTALDH1A1NPC1RAB9A
SCHEMBL14119373 0.84 PGR (0.38) PGRPNMTALDH1A1NPC1RAB9A
SCHEMBL25337616 0.84 PNMT (0.41) PGRPNMTALDH1A1NPC1RAB9A
SCHEMBL14119391 0.81 PGR (0.35) PGRPNMTALDH1A1NPC1RAB9A
SCHEMBL30103626 0.80 PGR (0.40) PGRPNMTALDH1A1NPC1RAB9A
SCHEMBL25217211 0.80 PGR (0.40) PGRPNMTALDH1A1NPC1RAB9A
SCHEMBL22289807 0.79 NPC1 (0.44) PGRPNMTALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3596065-B1 COMPOUNDS WITH ARYLAMINE STRUCTURES MERCK PATENT GMBH (DE) 2024-12-25 EP disclosed
US-20240254090-A1 COMPOUNDS WITH ARYLAMINE STRUCTURES MERCK PATENT GMBH (DE) 2024-08-01 US disclosed
EP-3535240-B1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2022-11-16 EP disclosed
US-11302870-B2 Materials for electronic devices MERCK PATENT GMBH (DE) 2022-04-12 US disclosed
CN-109824576-B Synthetic method of organic photoelectric material intermediate dimethylindenocarbazole 青岛海洋生物医药研究院股份有限公司 2021-01-19 CN disclosed
US-20200048207-A1 COMPOUNDS WITH ARYLAMINE STRUCTURES MERCK PATENT GMBH (DE) 2020-02-13 US disclosed
US-20190288206-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2019-09-19 US disclosed
WO-2018166932-A1 COMPOUNDS WITH ARYLAMINE STRUCTURES MERCK PATENT GMBH (DE) 2018-09-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11302870-B2 Materials for electronic devices EFNA1, PNMT, FLNB PGR 1650/4885PNMT 2/4885ALDH1A1 365/4885
US-20200048207-A1 COMPOUNDS WITH ARYLAMINE STRUCTURES DDT, NAT1, INMT PGR 1863/4885PNMT 4/4885ALDH1A1 318/4885
US-20190288206-A1 MATERIALS FOR ELECTRONIC DEVICES EFNA1, PNMT, FLNB PGR 1634/4885PNMT 2/4885ALDH1A1 337/4885
US-20240254090-A1 COMPOUNDS WITH ARYLAMINE STRUCTURES DDT, NAT1, INMT PGR 1863/4885PNMT 4/4885ALDH1A1 318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.